title: A network of substrates of the E3 ubiquitin ligases MDM2 and HUWE1 control apoptosis independently of p53.
abstract: In the intrinsic pathway of apoptosis, cell-damaging signals promote the release of cytochrome c from mitochondria, triggering activation of the Apaf-1 and caspase-9 apoptosome. The ubiquitin E3 ligase MDM2 decreases the stability of the proapoptotic factor p53. We show that it also coordinated apoptotic events in a p53-independent manner by ubiquitylating the apoptosome activator CAS and the ubiquitin E3 ligase HUWE1. HUWE1 ubiquitylates the antiapoptotic factor Mcl-1, and we found that HUWE1 also ubiquitylated PP5 (protein phosphatase 5), which indirectly inhibited apoptosome activation. Breast cancers that are positive for the tyrosine receptor kinase HER2 (human epidermal growth factor receptor 2) tend to be highly aggressive. In HER2-positive breast cancer cells treated with the HER2 tyrosine kinase inhibitor lapatinib, MDM2 was degraded and HUWE1 was stabilized. In contrast, in breast cancer cells that acquired resistance to lapatinib, the abundance of MDM2 was not decreased and HUWE1 was degraded, which inhibited apoptosis, regardless of p53 status. MDM2 inhibition overcame lapatinib resistance in cells with either wild-type or mutant p53 and in xenograft models. These findings demonstrate broader, p53-independent roles for MDM2 and HUWE1 in apoptosis and specifically suggest the potential for therapy directed against MDM2 to overcome lapatinib resistance.
authors: Department of Pharmacology and Toxicology, Geisel School of Medicine at Dartmouth, Hanover, NH 03755, USA. manabu.kurokawa@dartmouth.edu
authors: Manabu
authors: M
authors: Kurokawa
authors: Jiyeon
authors: J
authors: Kim
authors: Joseph
authors: J
authors: Geradts
authors: Kenkyo
authors: K
authors: Matsuura
authors: Liu
authors: L
authors: Liu
authors: Xu
authors: X
authors: Ran
authors: Wenle
authors: W
authors: Xia
authors: Thomas J
authors: TJ
authors: Ribar
authors: Ricardo
authors: R
authors: Henao
authors: Mark W
authors: MW
authors: Dewhirst
authors: Wun-Jae
authors: WJ
authors: Kim
authors: Joseph E
authors: JE
authors: Lucas
authors: Shaomeng
authors: S
authors: Wang
authors: Neil L
authors: NL
authors: Spector
authors: Sally
authors: S
authors: Kornbluth
mesh_terms: D000818:Animals; D017209:Apoptosis; D001943:Breast Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology; D045744:Cell Line, Tumor; D019008:Drug Resistance, Neoplasm / Q000187:drug effects; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology; D015151:Immunoblotting; D000077341:Lapatinib; D051379:Mice; D008819:Mice, Nude; D064549:Myeloid Cell Leukemia Sequence 1 Protein / Q000378:metabolism; D009687:Nuclear Proteins / Q000378:metabolism; D010749:Phosphoprotein Phosphatases / Q000378:metabolism; D010879:Piperazines / Q000494:pharmacology; D047428:Protein Kinase Inhibitors / Q000494:pharmacology; D051736:Proto-Oncogene Proteins c-mdm2 / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D011799:Quinazolines / Q000494:pharmacology; D034622:RNA Interference; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects; D013379:Substrate Specificity; D016159:Tumor Suppressor Protein p53 / Q000235:genetics / Q000378:metabolism*; D025521:Tumor Suppressor Proteins; D044767:Ubiquitin-Protein Ligases / Q000235:genetics / Q000378:metabolism*; D023041:Xenograft Model Antitumor Assays
chemical_list: D007093:Imidazoles; D000077341:Lapatinib; D064549:Myeloid Cell Leukemia Sequence 1 Protein; D009687:Nuclear Proteins; D010749:Phosphoprotein Phosphatases; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D051736:Proto-Oncogene Proteins c-mdm2; D011799:Quinazolines; D018719:Erb-b2 Receptor Tyrosine Kinases; D016159:Tumor Suppressor Protein p53; D025521:Tumor Suppressor Proteins; D044767:Ubiquitin-Protein Ligases; C579095:MCL1 protein, human; C482205:nutlin 3; C502830:HUWE1 protein, human; C089641:protein phosphatase 5
references: J Biol Chem. 1989 Feb 15;264(5):2431-7
references: 2492519
references: Mol Cell. 2008 Apr 25;30(2):239-47
references: 18439902
references: Science. 1996 Nov 8;274(5289):948-53
references: 8875929
references: Science. 2004 Feb 6;303(5659):844-8
references: 14704432
references: Oncogene. 2011 Oct 6;30(40):4163-74
references: 21499296
references: FEBS Lett. 1997 Dec 22;420(1):25-7
references: 9450543
references: Cell. 2007 Aug 24;130(4):638-50
references: 17719542
references: Mol Cell Biol. 2008 Sep;28(17):5494-506
references: 18591256
references: Cell. 2005 Jul 1;121(7):1085-95
references: 15989957
references: Cell Cycle. 2009 Jan 1;8(1):18-22
references: 19106609
references: Science. 2007 May 18;316(5827):1039-43
references: 17463250
references: Cell. 2005 Nov 4;123(3):409-21
references: 16269333
references: Science. 1990 Mar 2;247(4946):1079-82
references: 2408149
references: Science. 2001 Aug 3;293(5531):876-80
references: 11423618
references: Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):14801-6
references: 10611293
references: Crit Rev Oncol Hematol. 2004 Nov;52(2):103-16
references: 15501075
references: Cell. 2005 Jul 1;121(7):1071-83
references: 15989956
references: Science. 1987 Jan 9;235(4785):177-82
references: 3798106
references: Nat Cell Biol. 2008 Jun;10(6):643-53
references: 18488021
references: J Neurosci. 2005 Feb 23;25(8):2002-9
references: 15728840
references: Cell. 1988 Jul 1;54(1):105-15
references: 2898299
references: Science. 1990 Feb 16;247(4944):824-30
references: 2406902
references: Cell. 1992 Jun 26;69(7):1237-45
references: 1535557
references: Proc Natl Acad Sci U S A. 2006 May 16;103(20):7795-800
references: 16682622
references: Mol Biol Cell. 2007 Sep;18(9):3340-50
references: 17567951
references: Proc Natl Acad Sci U S A. 1995 Oct 24;92(22):10427-31
references: 7479798
references: Nat Med. 2011 Apr;17(4):461-9
references: 21399647
references: Nature. 1993 Apr 29;362(6423):857-60
references: 8479525
references: Proc Natl Acad Sci U S A. 2008 Mar 11;105(10):3933-8
references: 18316739
references: Hum Mutat. 2007 Jun;28(6):622-9
references: 17311302
references: Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):5021-6
references: 21385943
references: Nature. 1997 May 15;387(6630):299-303
references: 9153396
references: Cancer Cell. 2006 Dec;10(6):515-27
references: 17157791
references: J Clin Oncol. 2008 Mar 1;26(7):1066-72
references: 18212337
references: Cancer Cell. 2009 May 5;15(5):363-75
references: 19411066
references: Science. 1991 Jul 5;253(5015):49-53
references: 1905840
references: EMBO J. 2006 Jan 25;25(2):367-76
references: 16407978
references: Cancer Cell. 2011 Sep 13;20(3):341-56
references: 21907925
references: Mol Cancer Ther. 2010 May;9(5):1432-42
references: 20406946
references: Nature. 1997 May 15;387(6630):296-9
references: 9153395
references: Cell. 2008 Jul 11;134(1):62-73
references: 18614011
references: J Clin Oncol. 1999 Sep;17(9):2639-48
references: 10561337
references: Mol Pharmacol. 2008 Sep;74(3):807-22
references: 18544666
references: J Biol Chem. 2000 Mar 24;275(12):8945-51
references: 10722742